International Journal For Multidisciplinary Research
E-ISSN: 2582-2160
•
Impact Factor: 9.24
A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal
Home
Research Paper
Submit Research Paper
Publication Guidelines
Publication Charges
Upload Documents
Track Status / Pay Fees / Download Publication Certi.
Editors & Reviewers
View All
Join as a Reviewer
Get Membership Certificate
Current Issue
Publication Archive
Conference
Publishing Conf. with IJFMR
Upcoming Conference(s) ↓
Conferences Published ↓
IC-AIRCM-T3-2026
SPHERE-2025
AIMAR-2025
SVGASCA-2025
ICCE-2025
Chinai-2023
PIPRDA-2023
ICMRS'23
Contact Us
Plagiarism is checked by the leading plagiarism checker
Call for Paper
Volume 8 Issue 2
March-April 2026
Indexing Partners
Basti Karma in the Modulation of Inflammatory Markers in Amavata (Rheumatoid Arthritis): An Integrative Review
| Author(s) | Dr. Poojashree N.K, Prof. Dr. Arun B Jainer, Prof. Dr. Basavaraj G Saraganachari |
|---|---|
| Country | India |
| Abstract | Background: Rheumatoid arthritis (RA) is a chronic, systemic autoimmune inflammatory disorder characterized by symmetrical polyarthritis, progressive joint destruction, and persistently elevated inflammatory markers such as erythrocyte sedimentation rate (ESR), C reactive protein (CRP), rheumatoid factor (RF), and anti cyclic citrullinated peptide (anti CCP) antibodies. In Ayurveda, RA closely resembles Amavata, a disorder originating from Agnimandya leading to Ama formation and subsequent vitiation of Vata Dosha. Basti Chikitsa is considered the most effective therapeutic intervention for Vatavyadhi and is designated as Ardha Chikitsa due to its systemic influence. Objective: To critically evaluate classical Ayurvedic concepts and contemporary scientific evidence regarding the role of Basti Karma in modulating inflammatory markers in Amavata with special reference to rheumatoid arthritis. Methods: Classical Ayurvedic texts and their commentaries were reviewed alongside contemporary biomedical literature on RA, inflammatory markers, immunopathogenesis, the gut–immune axis, and rectal drug delivery. A conceptual correlation and integrative interpretative analysis were undertaken. Results: Available evidence suggests that Basti Karma exerts systemic anti inflammatory and immunomodulatory effects by correcting Agnimandya, facilitating Ama Nirharana, pacifying Vata Dosha, and modulating the gut–immune–neuroendocrine axis. Clinical studies report significant reductions in ESR and CRP levels with concurrent improvement in joint pain, swelling, and stiffness following Basti therapy. Conclusion: Basti Karma demonstrates considerable potential in the integrative management of Amavata/RA by addressing both clinical manifestations and underlying inflammatory pathology. Well designed randomized controlled trials with standardized Basti protocols and biomarker based outcomes are warranted to substantiate its role within integrative rheumatology. |
| Keywords | Amavata, Rheumatoid Arthritis, Basti Karma, Inflammatory Markers, Gut–Immune Axis |
| Field | Medical / Pharmacy |
| Published In | Volume 8, Issue 1, January-February 2026 |
| Published On | 2026-02-18 |
Share this

E-ISSN 2582-2160
CrossRef DOI is assigned to each research paper published in our journal.
IJFMR DOI prefix is
10.36948/ijfmr
Downloads
All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.
Powered by Sky Research Publication and Journals